35291 |
Medicine, General & Internal |
Real world data on follicular lymphoma patients treated by rituximab-c... |
KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196 |
김원석 |
2020 |
35290 |
Hematology |
Progression of AITL-like tumors in mice is driven by Tfh signature pro... |
BLOOD ADV 2020 10.1182/bloodadvances.2019001114 |
김원석 |
2020 |
35289 |
Biochemistry & Molecular Biology; Cell Biology; Immunology |
Pre-treatment serum IL-10 predicts the risk of secondary central nervo... |
CYTOKINE 2020 10.1016/j.cyto.2020.155048 |
김원석 |
2020 |
35288 |
Oncology |
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lym... |
J CLIN ONCOL 2020 10.1200/JCO.19.00172 |
김원석 |
2020 |
35287 |
Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences, Biomedical |
Impact of fear of cancer recurrence on survival among lymphoma patients |
PSYCHO-ONCOL 2020 10.1002/pon.5265 |
김원석 |
2020 |
35286 |
Oncology |
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wi... |
LANCET ONCOL 2020 10.1016/S1470-2045(19)30799-5 |
김원석 |
2020 |
35285 |
Hematology |
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgk... |
BLOOD 2020 10.1182/blood.2019003127 |
김원석 |
2020 |
35284 |
Oncology; Hematology |
A proposal for a new staging system for extranodal natural killer T-ce... |
LEUKEMIA 2020 10.1038/s41375-020-0740-1 |
김원석 |
2020 |
35283 |
Hematology |
A phase II study of etoposide, methylprednisolone, high-dose cytarabin... |
ANN HEMATOL 2020 10.1007/s00277-019-03891-9 |
김원석 |
2020 |
35282 |
Hematology |
A comprehensive analysis of adult patients with secondary hemophagocyt... |
ANN HEMATOL 2020 10.1007/s00277-020-04083-6 |
김원석 |
2020 |